An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus and LongActing Octreotide Trial in Polycystic Livers
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers
- Status
- COMPLETED
- Phase
- NA